This inventor holds 5 USPTO granted patents and 3 published patent applications and 12 EPO patents. Top assignees: Luye Pharma Ag, Acino Ag. Active years: 2015-2021.
Location History:
- München, DE (2015 - 2016)
- Munich, DE (2018 - 2021)
Company Filing History:
Years Active: 2015-2021
Title: Bjorn Schurad: Innovator in Transdermal Therapeutics
Introduction
Bjorn Schurad is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal therapeutic systems. His work focuses on innovative methods for administering active substances through the skin.
Latest Patents
Bjorn Schurad holds a patent for a transdermal therapeutic system designed for administering rivastigmine or its derivatives. This invention represents a breakthrough in the delivery of medication, enhancing the effectiveness and convenience of treatment for patients.
Career Highlights
Throughout his career, Schurad has been associated with Luye Pharma AG, a company known for its commitment to advancing pharmaceutical technologies. His role at the company has allowed him to work on cutting-edge projects that aim to improve patient care.
Collaborations
He has collaborated with Heike Prinz, contributing to the development of innovative solutions in the pharmaceutical industry.
Conclusion
Bjorn Schurad's work in transdermal therapeutics exemplifies the impact of innovation in medicine. His contributions continue to shape the future of drug delivery systems, benefiting patients worldwide.